Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, KORU MEDICAL SYSTEMS, INC. reported revenue of $41M, up 22.2% year over year. Operating margin was -7.2% and net margin -6.4%, on a free-cash-flow margin of -1.1% with capital expenditure at 2.3% of revenue. Every figure is computed directly from KRMD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $41M | -7.2% | -6.4% |
| FY2024 | $34M | -19.2% | -18.0% |
| FY2023 | $29M | -36.0% | -48.2% |
| FY2022 | $28M | -38.6% | -31.0% |
| FY2021 | $23M | -29.9% | -19.4% |
How does KRMD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.